Bladder News and Research

RSS

Neoprobe completes license amendment with The Dow Chemical

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has completed a license amendment with The Dow Chemical Company for a variety of antibodies used in its proprietary surgical oncology system called radioimmunoguided surgery or RIGS®.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

Watson Pharmaceuticals, Inc. today provided a detailed overview of its expanded global operations, enhanced supply chain capabilities and commercial and pipeline developments in its Brand and Generics businesses during an Investor Day meeting held in New York, NY.

22 Jan 2010

New genetic risk factor for Parkinson's disease identified

An international team of doctors and human geneticists has identified a new genetic risk factor for Parkinson's disease. The institutions involved in the study were the Institute of Human Genetics of Helmholtz Zentrum München and Technische Universität München, the Neurological Clinic of Ludwig-Maximilians-Universität Munich (LMU) and the Mitochondrial Research Group of Newcastle University, Newcastle upon Tyne, UK.

18 Jan 2010

New technique can restore facial movements in paralytic patients

Surgeons from UC Davis Medical Center have demonstrated that artificial muscles can restore the ability of patients with facial paralysis to blink, a development that could benefit the thousands of people each year who no longer are able to close their eyelids due to combat-related injuries, stroke, nerve injury or facial surgery.

18 Jan 2010

Study reveals interaction of genetic and environmental factors in the pathogenesis of Parkinson's disease

"Our study reveals the interaction of genetic and environmental factors such as dietary habits in the pathogenesis of Parkinson's disease," explained Dr. Matthias Elstner of the Neurological Clinic of LMU and Helmholtz Zentrum M-nchen, lead author of the study.

18 Jan 2010

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

Boston Scientific Corporation today announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures. This multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months.

17 Jan 2010

Spectrum Pharmaceuticals achieves its enrollment target in second of two apaziquone Phase 3 trials

Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.

13 Jan 2010

PET-CT imaging appears to detect cancer in patients with neurologic complications

A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.

12 Jan 2010

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

MinuteClinic, the retail health care division of CVS Caremark (NYSE: CVS) and the pioneer and largest provider of retail-based medical clinics in the United States, has become the first retail clinic to be re-accredited and earn the Joint Commission's Gold Seal of Approval(TM) for consecutive evaluation periods by having demonstrated compliance with The Joint Commission's national standards for health care quality and safety.

9 Jan 2010

AUA updates clinical practice guideline on female stress urinary incontinence

A complete evaluation, including an assessment of post-void residual volume, is key when evaluating a female patient for surgery to treat stress urinary incontinence (SUI), according to a new clinical practice guideline released today by the American Urological Association (AUA).

8 Jan 2010

OncoDiagnostic Laboratory acquired by Predictive Biosciences

Predictive Biosciences today announced that it has acquired Cleveland, Ohio based OncoDiagnostic Laboratory (“ODL”), a private, Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians nationwide.

7 Jan 2010

OncoGenex Pharmaceuticals receives grant funding for Phase 2 clinical trial of OGX-427

OncoGenex Pharmaceuticals, Inc., today announced that a randomized, controlled, investigator-sponsored Phase 2 clinical trial evaluating OGX-427 when administered as a monotherapy to patients with castrate resistant prostate cancer (CRPC) has received grant funding.

6 Jan 2010

U.S. market for urological devices to reach over $5.4 billion in 2016

According to a new global report series by iData Research, the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for urological devices is estimated to more than double in value by 2016, reaching over $5.4 billion.

6 Jan 2010

AUA experts urge to focus on urologic health conditions in upcoming year

This new year, make a resolution to improve your health and talk to your doctor about urologic conditions. Although urologic problems may seem embarrassing to talk about, these conditions are more common than you think and a delay in seeking medical attention could cause you unnecessary stress, prolong the problem and even increase your risk for a more serious condition.

30 Dec 2009

LUHS urogynecologists awarded $1M NIH Challenge Grant

The National Institutes of Health (NIH) has awarded a Challenge Grant for $1 million to Loyola University Health System (LUHS) urogynecologists Kimberly Kenton, MD, and Elizabeth Mueller, MD. This places them among the top 2 percent of researchers in the nation to receive this grant.

24 Dec 2009

VOA News examines obstetric fistula in Africa

VOA News examines obstetric fistula in Africa and looks at health officials' efforts to prevent and treat the condition.

24 Dec 2009

New project analyzes genetic sequence and variations of every gene expressed by 1,000 tumors

No two tumors are alike, but analyzing the genetics of cancers from different parts of the body may reveal surprising details useful for treatment and prevention.

22 Dec 2009

Four Latin American cancer patients receive treatment using RapidArc radiotherapy technology

Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme--an aggressive type of brain tumor.

22 Dec 2009

Abdominal surgery may increase risk of complications and death in older patients

The risk of complications and early death after commonly performed abdominal surgical procedures appears to be higher among older adults, according to a report in the December issue of Archives of Surgery, one of the JAMA/Archives journals.

22 Dec 2009

Bladder News and Research

Neoprobe completes license amendment with The Dow Chemical

Scott & White conducts DBS research for Parkinson's patients

Watson Pharmaceuticals provides detailed overview of its global operations at Investor Day meeting in NY

New genetic risk factor for Parkinson's disease identified

New technique can restore facial movements in paralytic patients

Study reveals interaction of genetic and environmental factors in the pathogenesis of Parkinson's disease

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

Spectrum Pharmaceuticals achieves its enrollment target in second of two apaziquone Phase 3 trials

PET-CT imaging appears to detect cancer in patients with neurologic complications

MinuteClinic re-accredited and earns the Joint Commission's Gold Seal of Approval

AUA updates clinical practice guideline on female stress urinary incontinence

OncoDiagnostic Laboratory acquired by Predictive Biosciences

OncoGenex Pharmaceuticals receives grant funding for Phase 2 clinical trial of OGX-427

U.S. market for urological devices to reach over $5.4 billion in 2016

AUA experts urge to focus on urologic health conditions in upcoming year

LUHS urogynecologists awarded $1M NIH Challenge Grant

VOA News examines obstetric fistula in Africa

New project analyzes genetic sequence and variations of every gene expressed by 1,000 tumors

Four Latin American cancer patients receive treatment using RapidArc radiotherapy technology

Abdominal surgery may increase risk of complications and death in older patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News